Prestige Consumer Healthcare
PBH
#3940
Rank
HK$23.30 B
Marketcap
HK$473.46
Share price
1.27%
Change (1 day)
-27.85%
Change (1 year)

Earnings for Prestige Consumer Healthcare (PBH)

Earnings in 2025 (TTM): HK$2.22 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are HK$1.11 Billion. In 2024 the company made an earning of HK$2.16 Billion, an increase over its 2023 earnings that were of -HK$0.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prestige Consumer Healthcare from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$2.22 B2.77%
2024 HK$2.16 B-405.61%
2023 -HK$0.71 Billion-134.07%
2022 HK$2.07 B10.21%
2021 HK$1.88 B12.88%
2020 HK$1.66 B-657.8%
2019 -HK$0.3 Billion-143.45%
2018 HK$0.68 B-50.46%
2017 HK$1.38 B52.98%
2016 HK$0.90 B-31.39%
2015 HK$1.32 B45.68%
2014 HK$0.90 B10.59%
2013 HK$0.82 B38.24%
2012 HK$0.59 B8.79%
2011 HK$0.54 B55.18%
2010 HK$0.35 B-123.77%
2009 -HK$1.49 Billion-446.47%
2008 HK$0.42 B8.03%
2007 HK$0.39 B-3.71%
2006 HK$0.41 B42.33%
2005 HK$0.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
HK$72.57 B 3,170.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$92.26 B 4,058.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-HK$10.84 Billion-588.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B 11,266.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$0.34 B-84.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$127.81 B 5,660.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
HK$170.69 B 7,593.06%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$46.69 B 2,004.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$7.84 B 253.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.35 B 2,755.21%๐Ÿ‡บ๐Ÿ‡ธ USA